Nifty

:

23349.90

Sensex

:

77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Login

Nifty
Sensex

:
:

23349.90
77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 524816 | NSE: NATCOPHARM

Watchlist

NSE BSE

1223.90

05-Jul-2024

Open
High
Low
Previous Close

1219.50
1240.00
1208.00
1215.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

760362
9295.05
1639.00
752.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

24,652.68
12.58
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

23,291.58
0.69%
3.42

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.09
15.86
27.16

EBITDA CAGR (%)

10 Years
5 Years
3 Years

23.43
24.62
46.06

PAT CAGR (%)

10 Years
5 Years
3 Years

26.28
24.68
101.38

P:E (Median)

8 Years
5 Years
3 Years

25.25
26.20
23.73

P:BV (Average)

8 Years
5 Years
3 Years

4.19
3.30
3.02

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.62
19.17
17.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,292.60 930.50 38.91% 1,236.90 1,048.30 17.99% 964.80 781.20 23.50% 625.30 413.00 51.40%
Expenses 501.90 488.20 2.81% 473.90 544.60 -12.98% 512.10 453.50 12.92% 387.00 345.50 12.01%
EBITDA 790.70 442.30 78.77% 763.00 503.70 51.48% 452.70 327.70 38.14% 238.30 67.50 253.04%
EBIDTM 61.17% 47.53% 61.69% 48.05% 46.92% 41.95% 38.11% 16.34%
Other Income 51.40 24.70 108.10% 39.80 14.60 172.60% 35.90 17.50 105.14% 29.50 18.60 58.60%
Interest 3.00 3.00 0.00% 4.40 3.20 37.50% 4.50 1.20 275.00% 3.80 3.00 26.67%
Depreciation 42.20 40.00 5.50% 40.40 39.90 1.25% 51.60 37.60 37.23% 40.40 38.10 6.04%
PBT 796.90 424.00 87.95% 758.00 475.20 59.51% 432.50 306.40 41.16% 223.60 45.00 396.89%
Tax 135.80 63.80 112.85% 121.70 69.90 74.11% 83.40 52.30 59.46% 31.60 7.70 310.39%
PAT 661.10 360.20 83.54% 636.30 405.30 56.99% 349.10 254.10 37.39% 192.00 37.30 414.75%
PATM 51.15% 38.71% 51.44% 38.66% 36.18% 32.53% 30.71% 9.03%
EPS 36.91 20.11 83.54% 35.53 22.63 57.00% 19.49 14.19 37.35% 10.72 2.08 415.38%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,371.10 1,031.40 32.94% 1,362.60 1,140.50 19.47% 1,068.30 897.90 18.98% 758.60 492.50 54.03%
Expenses 566.80 573.40 -1.15% 557.80 612.50 -8.93% 571.00 558.80 2.18% 490.50 386.60 26.88%
EBITDA 804.30 458.00 75.61% 804.80 528.00 52.42% 497.30 339.10 46.65% 268.10 105.90 153.16%
EBIDTM 58.66% 44.41% 59.06% 46.30% 46.55% 37.77% 35.34% 21.50%
Other Income 63.80 29.40 117.01% 48.10 19.70 144.16% 42.00 29.00 44.83% 37.00 20.80 77.88%
Interest 4.10 4.20 -2.38% 5.20 4.20 23.81% 6.20 2.70 129.63% 4.60 3.80 21.05%
Depreciation 45.80 43.60 5.05% 44.10 43.50 1.38% 55.50 41.00 35.37% 44.20 41.50 6.51%
PBT 818.20 439.60 86.12% 803.60 500.00 60.72% 477.60 324.40 47.23% 256.30 81.40 214.86%
Tax 141.70 70.60 100.71% 135.10 79.70 69.51% 91.30 48.60 87.86% 43.60 19.10 128.27%
PAT 676.50 369.00 83.33% 668.50 420.30 59.05% 386.30 275.80 40.07% 212.70 62.30 241.41%
PATM 49.34% 35.78% 49.06% 36.85% 36.16% 30.72% 28.04% 12.65%
EPS 37.84 20.61 83.60% 37.35 23.48 59.07% 21.58 15.11 42.82% 11.88 3.41 248.39%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,119.60 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30 2,091.30 1,958.00 1,021.40 715.55 Net Sales Growth 29.83% 51.80% 32.99% 6.91% -7.64% -9.87% -5.02% 6.81% 91.70% 42.74% Cost Of Goods Sold 518.00 525.80 485.60 502.10 472.30 369.80 317.60 388.50 572.80 256.30 170.70 Gross Profit 3,601.60 3,043.10 1,865.40 1,265.70 1,181.20 1,420.40 1,668.70 1,702.80 1,385.20 765.10 544.85 GP Margin 87.43% 85.27% 79.34% 71.60% 71.44% 79.34% 84.01% 81.42% 70.75% 74.91% 76.14% Total Expenditure 1,874.90 1,931.90 1,530.20 1,554.80 1,238.30 1,212.20 1,169.80 1,162.90 1,266.00 740.70 486.99 Power & Fuel Cost - 88.90 81.90 76.40 59.40 62.40 59.60 56.10 50.50 43.70 40.49 % Of Sales - 2.49% 3.48% 4.32% 3.59% 3.49% 3.00% 2.68% 2.58% 4.28% 5.66% Employee Cost - 454.90 425.70 410.10 380.00 356.10 340.20 312.20 232.10 171.90 116.19 % Of Sales - 12.75% 18.11% 23.20% 22.98% 19.89% 17.13% 14.93% 11.85% 16.83% 16.24% Manufacturing Exp. - 341.70 269.90 340.80 160.50 230.40 257.50 175.10 134.20 100.60 65.41 % Of Sales - 9.57% 11.48% 19.28% 9.71% 12.87% 12.96% 8.37% 6.85% 9.85% 9.14% General & Admin Exp. - 253.10 155.70 122.50 92.60 111.20 103.90 96.00 78.30 56.90 48.57 % Of Sales - 7.09% 6.62% 6.93% 5.60% 6.21% 5.23% 4.59% 4.00% 5.57% 6.79% Selling & Distn. Exp. - 117.40 59.50 27.00 29.20 22.60 33.50 98.00 128.80 88.40 34.29 % Of Sales - 3.29% 2.53% 1.53% 1.77% 1.26% 1.69% 4.69% 6.58% 8.65% 4.79% Miscellaneous Exp. - 150.10 51.90 75.90 44.30 59.70 57.50 37.00 69.30 22.90 34.29 % Of Sales - 4.21% 2.21% 4.29% 2.68% 3.33% 2.89% 1.77% 3.54% 2.24% 1.58% EBITDA 2,244.70 1,637.00 820.80 213.00 415.20 578.00 816.50 928.40 692.00 280.70 228.56 EBITDA Margin 54.49% 45.87% 34.91% 12.05% 25.11% 32.29% 41.11% 44.39% 35.34% 27.48% 31.94% Other Income 156.60 104.70 109.40 94.60 103.50 123.80 129.80 39.40 13.20 12.90 13.57 Interest 15.70 14.50 8.60 13.30 11.30 20.60 18.80 14.70 17.50 21.90 30.13 Depreciation 174.60 171.90 150.90 138.40 115.20 98.10 80.10 65.50 53.60 50.20 42.46 PBT 2,211.00 1,555.30 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 169.54 Tax 372.50 248.70 133.60 16.80 82.70 108.60 180.30 189.40 139.30 45.00 1.48 Tax Rate 16.85% 15.99% 17.33% 10.78% 21.09% 18.62% 21.28% 21.34% 21.97% 20.32% 0.96% PAT 1,838.50 1,306.60 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 152.93 PAT before Minority Interest 1,838.50 1,306.60 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 152.93 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 44.63% 36.61% 27.10% 7.87% 18.72% 26.51% 33.59% 33.39% 25.27% 17.28% 21.37% PAT Growth 73.95% 105.09% 358.02% -55.06% -34.77% -28.87% -4.45% 41.11% 180.34% 15.41% EPS 102.65 72.95 35.57 7.77 17.28 26.49 37.25 38.98 27.63 9.85 8.54

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,560.60 3,998.80 2,707.10 1,944.80 2,052.10 1,915.00 2,094.50 2,184.80 2,020.20 1,141.30 825.28 Net Sales Growth 28.02% 47.72% 39.20% -5.23% 7.16% -8.57% -4.13% 8.15% 77.01% 38.29% Cost Of Goods Sold 662.60 667.90 583.20 528.40 483.70 354.40 332.70 411.10 599.10 341.10 242.37 Gross Profit 3,898.00 3,330.90 2,123.90 1,416.40 1,568.40 1,560.60 1,761.80 1,773.70 1,421.10 800.20 582.90 GP Margin 85.47% 83.30% 78.46% 72.83% 76.43% 81.49% 84.12% 81.18% 70.34% 70.11% 70.63% Total Expenditure 2,186.10 2,247.40 1,795.40 1,681.30 1,448.30 1,332.40 1,299.70 1,256.40 1,336.80 868.70 611.90 Power & Fuel Cost - 88.90 81.90 76.40 61.10 62.40 59.60 56.20 50.50 43.70 43.24 % Of Sales - 2.22% 3.03% 3.93% 2.98% 3.26% 2.85% 2.57% 2.50% 3.83% 5.24% Employee Cost - 525.00 486.70 444.80 414.90 375.00 355.90 325.60 243.20 189.60 136.92 % Of Sales - 13.13% 17.98% 22.87% 20.22% 19.58% 16.99% 14.90% 12.04% 16.61% 16.59% Manufacturing Exp. - 368.40 279.60 353.60 165.70 243.30 276.40 182.60 141.20 105.20 73.04 % Of Sales - 9.21% 10.33% 18.18% 8.07% 12.70% 13.20% 8.36% 6.99% 9.22% 8.85% General & Admin Exp. - 313.00 208.80 152.80 242.90 132.60 126.40 105.50 88.10 73.40 63.66 % Of Sales - 7.83% 7.71% 7.86% 11.84% 6.92% 6.03% 4.83% 4.36% 6.43% 7.71% Selling & Distn. Exp. - 153.00 96.10 43.70 34.40 98.10 90.00 136.90 143.20 91.60 37.36 % Of Sales - 3.83% 3.55% 2.25% 1.68% 5.12% 4.30% 6.27% 7.09% 8.03% 4.53% Miscellaneous Exp. - 131.20 59.10 81.60 45.60 66.60 58.70 38.50 71.50 24.10 37.36 % Of Sales - 3.28% 2.18% 4.20% 2.22% 3.48% 2.80% 1.76% 3.54% 2.11% 1.86% EBITDA 2,374.50 1,751.40 911.70 263.50 603.80 582.60 794.80 928.40 683.40 272.60 213.38 EBITDA Margin 52.07% 43.80% 33.68% 13.55% 29.42% 30.42% 37.95% 42.49% 33.83% 23.89% 25.86% Other Income 190.90 128.10 128.50 99.00 106.00 107.40 130.20 40.40 13.90 9.90 14.91 Interest 20.10 19.20 14.50 17.70 13.30 21.50 19.30 15.40 18.50 22.90 31.68 Depreciation 189.60 186.80 163.80 142.60 116.90 99.80 81.00 66.20 54.40 51.00 47.27 PBT 2,355.70 1,673.50 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 149.34 Tax 411.70 285.20 146.60 32.20 137.20 110.60 182.30 192.00 139.50 52.80 3.95 Tax Rate 17.48% 17.04% 17.01% 15.92% 23.67% 19.45% 22.11% 21.64% 22.34% 25.31% 2.94% PAT 1,944.00 1,388.30 715.30 170.00 440.90 460.80 644.40 696.20 486.00 157.10 134.62 PAT before Minority Interest 1,944.80 1,388.30 715.30 170.00 442.40 458.10 642.40 695.20 484.90 155.80 130.27 Minority Interest 0.80 0.00 0.00 0.00 -1.50 2.70 2.00 1.00 1.10 1.30 4.35 PAT Margin 42.63% 34.72% 26.42% 8.74% 21.49% 24.06% 30.77% 31.87% 24.06% 13.77% 16.31% PAT Growth 72.43% 94.09% 320.76% -61.44% -4.32% -28.49% -7.44% 43.25% 209.36% 16.70% EPS 108.54 77.52 39.94 9.49 24.62 25.73 35.98 38.87 27.14 8.77 7.52

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 5,592.30 4,702.00 4,191.90 4,091.10 3,869.50 3,563.20 3,125.40 1,699.70 1,336.30 878.99 Share Capital 35.80 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 33.23 Total Reserves 5,556.50 4,665.50 4,152.00 4,037.00 3,809.50 3,495.80 3,064.30 1,649.40 1,291.80 845.76 Non-Current Liabilities 69.00 116.90 134.90 142.90 117.50 83.10 47.00 37.70 27.90 117.53 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 96.28 Unsecured Loans 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 70.90 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 9.19 Current Liabilities 885.60 569.00 651.20 518.50 659.70 709.80 563.80 609.70 478.50 398.31 Trade Payables 183.30 182.40 141.20 139.50 234.20 201.80 245.40 251.40 270.10 115.34 Other Current Liabilities 204.70 201.40 104.00 111.10 93.40 108.50 131.70 122.80 110.90 113.32 Short Term Borrowings 363.20 159.90 389.00 255.10 313.10 384.50 173.00 220.60 96.00 168.54 Short Term Provisions 134.40 25.30 17.00 12.80 19.00 15.00 13.70 14.90 1.50 1.11 Total Liabilities 6,546.90 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83 Net Block 2,286.70 2,233.80 2,174.20 2,005.90 1,574.50 1,214.90 1,015.30 829.00 705.60 572.74 Gross Block 3,359.50 3,157.10 2,977.80 2,678.30 2,133.70 1,678.20 1,399.60 1,151.00 975.90 783.12 Accumulated Depreciation 1,072.80 923.30 803.60 672.40 559.20 463.30 384.30 322.00 270.30 210.39 Non Current Assets 3,136.50 2,893.20 2,810.30 2,584.00 2,406.80 2,088.70 1,682.00 1,312.00 1,051.80 950.65 Capital Work in Progress 133.90 62.80 128.70 223.40 517.80 637.50 480.00 336.20 211.90 100.77 Non Current Investment 577.80 517.60 430.40 294.90 186.10 117.60 101.30 85.90 71.70 131.15 Long Term Loans & Adv. 111.50 78.80 72.40 55.60 124.30 110.40 83.10 60.40 62.00 142.47 Other Non Current Assets 26.60 0.20 4.60 4.20 4.10 8.30 2.30 0.50 0.60 3.52 Current Assets 3,410.40 2,494.70 2,167.70 2,168.50 2,239.90 2,267.40 2,054.20 1,035.10 790.90 444.18 Current Investments 163.90 139.90 119.60 42.10 5.00 126.80 48.30 8.90 22.10 0.12 Inventories 596.90 616.00 697.70 769.20 524.40 508.40 425.80 336.90 351.90 198.35 Sundry Debtors 1,076.60 793.10 575.60 399.80 536.70 491.60 606.00 468.90 255.80 188.96 Cash & Bank 864.90 412.00 100.90 262.80 54.10 262.70 172.10 25.10 40.20 7.19 Other Current Assets 708.10 57.60 78.10 95.20 1,119.70 877.90 802.00 195.30 120.90 49.57 Short Term Loans & Adv. 622.00 476.10 595.80 599.40 1,025.90 769.50 748.80 169.60 95.50 43.99 Net Current Assets 2,524.80 1,925.70 1,516.50 1,650.00 1,580.20 1,557.60 1,490.40 425.40 312.40 45.87 Total Assets 6,546.90 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 5,853.10 4,873.80 4,263.60 4,121.60 3,773.50 3,489.00 3,072.20 1,649.30 1,295.70 846.05 Share Capital 35.80 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 33.23 Total Reserves 5,817.30 4,837.30 4,223.70 4,067.60 3,713.60 3,421.70 3,011.40 1,599.00 1,251.20 812.82 Non-Current Liabilities 61.00 100.50 135.10 142.90 117.80 83.40 47.10 37.70 28.00 119.23 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 94.03 Unsecured Loans 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 2.99 Long Term Provisions 70.90 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 9.50 Current Liabilities 972.80 683.10 710.40 525.60 685.30 728.70 592.00 626.50 493.10 413.74 Trade Payables 235.50 263.80 161.80 146.20 255.40 217.00 269.10 262.70 275.60 125.30 Other Current Liabilities 238.90 227.30 126.70 99.50 95.90 109.80 133.40 127.10 114.20 118.56 Short Term Borrowings 363.20 165.00 404.00 265.80 315.00 386.30 173.20 221.60 98.40 168.54 Short Term Provisions 135.20 27.00 17.90 14.10 19.00 15.60 16.30 15.10 4.90 1.33 Total Liabilities 6,886.90 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05 Net Block 2,490.80 2,426.90 2,311.80 2,023.20 1,584.40 1,227.20 1,018.60 833.00 710.10 709.97 Gross Block 3,603.20 3,375.10 3,126.90 2,702.10 2,148.70 1,694.50 1,407.60 1,158.70 983.30 939.98 Accumulated Depreciation 1,112.40 948.20 815.10 678.90 564.30 467.30 389.00 325.70 273.20 225.82 Non Current Assets 2,863.40 2,657.10 2,622.40 2,447.10 2,262.20 1,955.90 1,584.40 1,230.30 984.70 901.08 Capital Work in Progress 137.30 64.30 129.50 223.40 518.00 637.60 480.00 336.30 211.80 128.96 Non Current Investment 95.90 87.30 104.40 151.90 83.60 19.90 8.10 0.10 0.10 1.57 Long Term Loans & Adv. 112.70 78.30 72.00 44.30 72.00 62.80 75.40 60.40 62.10 57.03 Other Non Current Assets 26.70 0.30 4.70 4.30 4.20 8.40 2.30 0.50 0.60 3.54 Current Assets 4,023.50 3,000.30 2,486.70 2,344.80 2,325.60 2,347.20 2,130.70 1,087.30 837.00 482.97 Current Investments 443.50 305.00 203.70 151.80 28.70 148.70 68.40 32.10 22.10 0.12 Inventories 700.50 742.90 762.00 798.20 558.00 529.00 438.40 348.90 357.30 220.00 Sundry Debtors 1,188.90 856.10 620.60 412.90 551.30 506.20 637.50 475.20 261.60 192.43 Cash & Bank 952.90 546.30 206.10 283.50 66.00 279.50 183.70 35.80 45.20 13.36 Other Current Assets 737.70 64.40 88.10 94.70 1,121.60 883.80 802.70 195.30 150.80 57.06 Short Term Loans & Adv. 638.20 485.60 606.20 603.70 1,030.00 776.40 749.50 169.50 125.40 40.97 Net Current Assets 3,050.70 2,317.20 1,776.30 1,819.20 1,640.30 1,618.50 1,538.70 460.80 343.90 69.23 Total Assets 6,886.90 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 1,196.40 784.40 57.70 183.50 422.50 698.80 476.40 329.80 189.90 124.55 PBT 1,555.30 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 154.41 Adjustment 150.90 85.40 118.50 58.40 45.20 12.10 74.40 99.80 81.70 62.73 Changes in Working Capital -257.80 76.70 -184.20 -190.20 -100.70 14.20 -281.20 -281.70 -68.50 -72.49 Cash after chg. in Working capital 1,448.40 932.80 90.20 260.40 527.60 873.70 680.80 452.20 234.70 144.64 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -252.00 -148.40 -32.50 -76.90 -105.10 -174.90 -204.40 -122.40 -44.80 -20.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -960.50 -436.60 -92.50 -3.20 -165.00 -645.20 -1,131.10 -290.60 -249.30 -147.95 Net Fixed Assets -273.50 -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 Net Investments -84.20 -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 -42.37 Others -602.80 -215.70 325.30 392.90 117.50 -114.30 -683.90 9.80 17.14 -5.45 Cash from Financing Activity -237.30 -346.80 35.60 -183.10 -261.10 -52.20 652.00 -45.60 151.40 22.80 Net Cash Inflow / Outflow -1.40 1.00 0.80 -2.80 -3.60 1.40 -2.70 -6.40 92.00 -0.59 Opening Cash & Equivalents 6.90 5.90 5.10 7.90 11.50 10.10 12.80 19.20 -170.00 6.86 Closing Cash & Equivalent 5.50 6.90 5.90 5.10 7.90 11.50 10.10 12.80 -76.80 6.27

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 1,211.60 849.10 46.50 298.80 417.30 668.80 463.60 345.80 112.20 92.67 PBT 1,673.50 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 134.22 Adjustment 133.80 102.00 123.90 62.10 54.00 14.30 75.60 100.20 90.50 68.14 Changes in Working Capital -309.40 62.70 -231.40 -212.90 -97.60 8.60 -294.60 -253.00 -140.70 -85.96 Cash after chg. in Working capital 1,497.90 1,026.60 94.70 428.80 525.10 847.60 668.20 471.60 158.40 116.41 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -286.30 -177.50 -48.20 -130.00 -107.80 -178.80 -204.60 -125.80 -46.20 -23.74 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,032.70 -477.10 -5.30 -103.30 -167.00 -612.20 -1,115.50 -299.40 -175.50 -114.75 Net Fixed Assets -273.50 -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 Net Investments -84.20 -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 -42.37 Others -675.00 -256.20 412.50 292.80 115.50 -81.30 -668.30 1.00 90.94 27.75 Cash from Financing Activity -246.90 -363.00 34.80 -185.70 -250.80 -50.90 650.90 -47.70 154.00 29.07 Net Cash Inflow / Outflow -68.00 9.00 76.00 9.80 -0.50 5.70 -1.00 -1.30 90.70 6.99 Opening Cash & Equivalents 131.90 111.10 25.80 19.80 28.30 21.70 23.50 24.20 -164.10 10.22 Closing Cash & Equivalent 70.40 131.90 111.10 25.80 19.80 28.30 21.70 23.50 -74.20 12.44

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 312.42 257.64 229.51 223.21 211.31 193.55 168.09 96.52 76.24 52.90 ROA 21.90% 12.29% 2.86% 6.59% 10.54% 16.49% 22.95% 23.62% 10.90% 11.90% ROE 25.38% 14.33% 3.37% 7.82% 12.86% 20.11% 29.18% 32.87% 16.00% 18.97% ROCE 29.02% 16.51% 3.79% 9.46% 14.85% 23.91% 34.58% 38.71% 18.48% 17.10% Fixed Asset Turnover 1.15 0.78 0.65 0.70 0.99 1.41 1.65 1.88 1.20 0.99 Receivable days 90.80 104.18 96.61 101.41 99.38 92.04 93.04 66.04 76.63 76.52 Inventory Days 58.90 100.00 145.29 140.07 99.81 78.34 66.02 62.77 94.81 90.45 Payable days 126.93 121.62 102.03 144.40 66.65 73.69 81.82 79.78 95.04 82.23 Cash Conversion Cycle 22.77 82.56 139.87 97.08 132.54 96.69 77.23 49.02 76.39 84.74 Total Debt/Equity 0.06 0.03 0.09 0.06 0.08 0.11 0.06 0.13 0.08 0.35 Interest Cover 108.26 90.62 12.72 35.71 29.31 46.07 61.38 37.23 11.11 6.12

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 326.99 267.06 233.44 224.88 206.04 189.49 165.22 93.63 73.91 50.91 ROA 22.13% 13.29% 3.43% 9.43% 10.30% 16.02% 23.05% 23.43% 9.72% 10.10% ROE 25.88% 15.66% 4.06% 11.27% 12.71% 19.75% 29.70% 33.21% 14.62% 16.57% ROCE 30.08% 18.06% 4.86% 13.99% 14.82% 23.71% 35.28% 39.21% 18.04% 15.62% Fixed Asset Turnover 1.24 0.89 0.76 0.86 1.07 1.47 1.72 1.93 1.23 0.95 Receivable days 86.16 93.53 85.10 84.44 93.77 91.36 92.22 65.12 70.27 67.76 Inventory Days 60.81 95.32 128.47 118.77 96.38 77.28 65.25 62.41 89.35 87.33 Payable days 136.43 133.18 106.38 151.52 65.96 72.53 81.42 78.30 85.42 73.36 Cash Conversion Cycle 10.54 55.67 107.20 51.68 124.19 96.11 76.05 49.23 74.21 81.73 Total Debt/Equity 0.06 0.03 0.09 0.06 0.08 0.11 0.06 0.14 0.09 0.37 Interest Cover 88.16 60.44 12.42 44.58 27.45 43.73 58.61 34.75 10.11 5.24

Top Investors:

life insurance corporation of india - p & gs fund

belgrave investment fund

tata nifty 500 multicap india manufacturing 50:30:20 index fund

akash bhanshali

investor education and protection fund (iepf)

Annual Reports:

News Update:

Natco Pharma’s arm makes $8 million investment in eGenesis
4th Sep 2024, 12:56 PM

With this, the company is investing in new-age therapeutic programmes addressing critical unmet medical needs.
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback